A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C
Clinical trial NCT00118768 · COMPLETED
Trial details
- NCT number
- NCT00118768
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.